Treatment of XXXX in the transplant era.

@entity1 @entity157 @entity409 @entity82
BACKGROUND: @entity157 ( @entity157 ) is one of the most frequent @entity409 . It is clearly related to @entity82 , especially to that caused by liverbound viruses. This study addresses the behavior of this disease in @entity1 treated under different protocols at two third-level hospitals. METHODS: we conducted a longitudinal, prospective and retrospective study including @entity1 diagnosed with @entity157 and invasively treated at Hermanos Ameijeiras and Juan Canalejo Hospitals. Subjects were grouped according to treatment and were compared with those @entity1 who underwent liver transplant. Mean comparison tests were used as well as survival analysis. RESULTS: overall recurrence patterns showed variable recurrence for all @entity1 with a clear benefit for the transplanted group of @entity1 including those with expanded criteria. Overall survival analysis at 3, 5 and 10 years showed that ( @entity1 ) survival was 70%, 59% and 55%, respectively, for the transplanted group. On the other hand, those @entity1 who did not undergo transplant showed significantly lower survival rates of 40%, 17% and 9%, respectively. CONCLUSIONS: this study, like others, demonstrated a clear benefit for liver transplant in the treatment of @entity157 . This is more evident in @entity1 with an underlying @entity409 , as long as low-recurrence selection criteria are considered. These results are important in the evaluation of effectiveness of treatments considering both groups are comparable.
